Home NDC 82829-002 IZERVAY
Product NDC 82829-002
11-digit product format 828290002
Labeler code 82829
Product ID 82829-002_7fc0afa6-193a-413b-b5be-39c1069b1110
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name avacincaptad pegol
Dosage form INJECTION
Route INTRAVITREAL
Labeler Astellas Pharma US, Inc.
Application NDA217225
Marketing category NDA
Marketing start 2023-08-19
Substance AVACINCAPTAD PEGOL SODIUM
Active strength 20 mg/mL
Pharmacologic classes Complement Inhibitor [EPC], Complement Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217225-001 IZERVAY AVACINCAPTAD PEGOL SODIUM EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217225-001 8236773 2026-11-11 U-3673 2023-08-31 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 N217225-001 12016875 2034-07-11 U-3673 2024-10-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 7579456 2025-02-14 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 9617546 2025-02-14 U-3673 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 b8a1b40f171c…
Additional Listing Data#
Finished product Yes
Brand name base IZERVAY
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AVACINCAPTAD PEGOL SODIUM 20 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination K86ENL12I5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2645112 Internal RxNorm lookup 2645118 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 82829-002-01 IZERVAY 0.35 mL in 1 VIAL, SINGLE-DOSE INJECTION 0.35 9 82829-002-01 IZERVAY 1 in 1 CARTON INJECTION 1 9 82829-002-99 IZERVAY 1 in 1 CARTON INJECTION 1 9 82829-002-99 IZERVAY 0.35 mL in 1 VIAL, SINGLE-DOSE INJECTION 0.35 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 82829-002 IZERVAY (AVACINCAPTAD PEGOL) INJECTION [ASTELLAS PHARMA US, INC.] 8 Current NDC, 4 package rows 20250316_1642fe6a-dc26-4d20-ae6e-654af744e3bd.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 82829-002-01 82829000201 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-01) / .35 mL in 1 VIAL, SINGLE-DOSE 2023-08-19 No No Current 82829-002-99 82829000299 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-99) / .35 mL in 1 VIAL, SINGLE-DOSE 2023-08-19 Yes No Current